Remission and relapse of autoimmune pancreatitis: Focusing on corticosteroid treatment

Pancreas

Volumn 39, Issue 5, 2010, Pages 555-560

  Kim, Hee Man ^a,b   Chung, Moon Jae ^a   Chung, Jae Bock ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Catholic Kwandong University   (South Korea)

Author keywords

autoimmune pancreatitis; corticosteroid; relapse; remission

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; IMMUNOGLOBULIN G4; AUTOANTIBODY; IMMUNOGLOBULIN G;

AUTOIMMUNE PANCREATITIS; BILE DUCT OBSTRUCTION; CYSTIC FIBROSIS; DIABETES MELLITUS; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG MEGADOSE; FOLLOW UP; GENETIC SUSCEPTIBILITY; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOPATHOGENESIS; LYMPHOCYTIC INFILTRATION; PANCREAS ISLET; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE RISK; RECURRENT DISEASE; RELAPSE; REMISSION; RETROPERITONEAL FIBROSIS; REVIEW; RISK ASSESSMENT; TREATMENT INDICATION; TREATMENT RESPONSE; AUTOIMMUNE DISEASES; BLOOD; FIBROSIS; PANCREAS DUCT; PANCREATITIS, CHRONIC; PATHOLOGY;

ADRENAL CORTEX HORMONES; AUTOANTIBODIES; AUTOIMMUNE DISEASES; FIBROSIS; HUMANS; IMMUNOGLOBULIN G; PANCREATIC DUCTS; PANCREATITIS, CHRONIC; RECURRENCE; REMISSION INDUCTION;

EID: 77954115277     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPA.0b013e3181c8b4a5     Document Type: Review

References (39)

1. Chari ST, Smyrk TC, Levy MJ, et al. Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience. Clin Gastroenterol Hepatol. 2006;4:1010-1016.
2. Kamisawa T, Okamoto A. IgG4-related sclerosing disease. World J Gastroenterol. 2008;14:3948-3955.
3. Okazaki K, Uchida K, Fukui T. Recent advances in autoimmune pancreatitis: concept, diagnosis, and pathogenesis. J Gastroenterol. 2008;43:409-418.
4. Ryu JK, Chung JB, Park SW, et al. Review of 67 patients with autoimmune pancreatitis in Korea: a multicenter nationwide study. Pancreas. 2008;37:377-385.
5. Okazaki K, Kawa S, Kamisawa T, et al. Clinical diagnostic criteria of autoimmune pancreatitis: revised proposal. J Gastroenterol. 2006;41:626-631.
6. Otsuki M, Chung JB, Okazaki K, et al. Asian diagnostic criteria for autoimmune pancreatitis: consensus of the Japan-Korea symposium on autoimmune pancreatitis. J Gastroenterol. 2008;43:403-408.
7. Ito T, Nakano I, Koyanagi S, et al. Autoimmune pancreatitis as a new clinical entity. Three cases of autoimmune pancreatitis with effective steroid therapy. Dig Dis Sci. 1997;42:1458-1468.
8. Ryu JK, Lee JK, Kim YT, et al. Clinical features of chronic pancreatitis in Korea: a multicenter nationwide study. Digestion. 2005;72:207-211.
9. Okazaki K. Autoimmune pancreatitis is increasing in Japan. Gastroenterology. 2003;125:1557-1558.
10. Pearson RK, Longnecker DS, Chari ST, et al. Controversies in clinical pancreatology: autoimmune pancreatitis: does it exist? Pancreas. 2003;27:1-13.
11. Chari ST, Murray JA. Autoimmune pancreatitis, part II: the relapse. Gastroenterology. 2008;134:625-628.
12. Ghazale A, Chari ST. Optimizing corticosteroid treatment for autoimmune pancreatitis. Gut. 2007;56:1650-1652.
13. Nishino T, Toki F, Oyama H, et al. Biliary tract involvement in autoimmune pancreatitis. Pancreas. 2005;30:76-82.
14. Kamisawa T, Shimosegawa T, Okazaki K, et al. Standard steroid treatment for autoimmune pancreatitis. Gut. 2009;58:1504-1507.
15. Raina A, Yadav D, Krasinskas AM, et al. Evaluation and management of autoimmune pancreatitis: experience at a large US center. Am J Gastroenterol. 2009;104:2295-2306.
16. Uchida K, Yazumi S, Nishio A, et al. Long-term outcome of autoimmune pancreatitis. J Gastroenterol. 2009;44:726-732.
17. Park DH, Kim MH, Oh HB, et al. Substitution of aspartic acid at position 57 of the DQA1 affects relapse of autoimmune pancreatitis. Gastroenterology. 2008;134:440-446.
18. Kamisawa T, Okamoto A, Wakabayashi T, et al. Appropriate steroid therapy for autoimmune pancreatitis based on long-term outcome. Scand J Gastroenterol. 2008;43:609-613.
19. Church NI, Pereira SP, Deheragoda MG, et al. Autoimmune pancreatitis: clinical and radiological features and objective response to steroid therapy in a UK series. Am J Gastroenterol. 2007;102:2417-2425.
20. Hirano K, Tada M, Isayama H, et al. Long-term prognosis of autoimmune pancreatitis with and without corticosteroid treatment. Gut. 2007;56:1719-1724.
21. Kubota K, Iida H, Fujisawa T, et al. Clinical factors predictive of spontaneous remission or relapse in cases of autoimmune pancreatitis. Gastrointest Endosc. 2007;66:1142-1151.
22. Nishino T, Toki F, Oyama H, et al. Long-term outcome of autoimmune pancreatitis after oral prednisolone therapy. Intern Med. 2006;45:497-501.
23. Wakabayashi T, Kawaura Y, Satomura Y, et al. Long-term prognosis of duct-narrowing chronic pancreatitis: strategy for steroid treatment. Pancreas. 2005;30:31-39.
24. Nishimori I, Okazaki K, Suda K, et al. Treatment for autoimmune pancreatitis [in Japanese]. J Jpn Pancreas Soc. 2005;20:343-348.
25. Ito T, Nishimori I, Inoue N, et al. Treatment for autoimmune pancreatitis: consensus on the treatment for patients with autoimmune pancreatitis in Japan. J Gastroenterol. 2007;42(S18):50-58. (Pubitemid 46863938)
26. Takayama M, Hamano H, Ochi Y, et al. Recurrent attacks of autoimmune pancreatitis results in pancreatic stone formation. Am J Gastroenterol. 2004;99:932-937.
27. Zamboni G, Luttges J, Capelli P, et al. Histopathological features of diagnostic and clinical relevance in autoimmune pancreatitis: a study on 53 resection specimens and 9 biopsy specimens. Virchows Arch. 2004;445:552-563.
28. Horiuchi A, Kawa S, Hamano H, et al. ERCP features in 27 patients with autoimmune pancreatitis. Gastrointest Endosc. 2002;55:494-499.
29. Okazaki K, Chiba T, Uchida K. Recent concept of autoimmune-related pancreatitis. J Gastroenterol. 2001;36:293-302.
30. Hamano H, Kawa S, Horiuchi A, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med. 2001;344:732-738.
31. Kamisawa T, Okamoto A. Prognosis of autoimmune pancreatitis. J Gastroenterol. 2007;42:59-62.
32. Gardner TB, Chari ST. Autoimmune pancreatitis. Gastroenterol Clin North Am. 2008;37:439-460.
33. Kamisawa T, Yoshiike M, Egawa N, et al. Treating patients with autoimmune pancreatitis: Results from a long-term follow-up study. Pancreatology. 2005;5:234-238.
34. Greenberger NJ. Autoimmune pancreatitis: time for a collective effort. Gastrointest Endosc. 2007;66:1152-1153.
35. Tanaka S, Kobayashi T, Nakanishi K, et al. Corticosteroid-responsive diabetes mellitus associated with autoimmune pancreatitis: pathological examinations of the endocrine and exocrine pancreas. Ann N Y Acad Sci. 2002;958:152-159.
36. Tanaka S, Kobayashi T, Nakanishi K, et al. Corticosteroid-responsive diabetes mellitus associated with autoimmune pancreatitis. Lancet. 2000;356:910-911.
37. Finkelberg DL, Sahani D, Deshpande V, et al. Autoimmune pancreatitis. N Engl J Med. 2006;355:2670-2676.
38. Song Y, Wang D, Zhang W, et al. Diagnosis and management of autoimmune pancreatitis: experience from China. World J Gastroenterol. 2008;14:601-606.
39. Lin LF, Huang PT, Ho KS, et al. Autoimmune chronic pancreatitis. J Chin Med Assoc. 2008;71:14-22.